Caribou Biosciences, Inc. (CRBU)
NASDAQ·Healthcare·Biotechnology
$2.10
-1.64%
Mkt Cap $205.84M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | $2.21M | $3.94M | +78.57% | -$0.33 | -$0.28 | +15.15% | — | — |
| Q4 2025 Nov 12, 2025 | $1.96M | $2.20M | +12.32% | -$0.36 | -$0.30 | +16.67% | — | — |
| Q3 2025 Aug 12, 2025 | $1.53M | $2.67M | +74.09% | -$0.40 | -$0.35 | +12.50% | — | — |
| Q2 2025 May 8, 2025 | $1.85M | $2.35M | +27.09% | -$0.43 | -$0.43 | +0.00% | — | — |
| Q1 2025 Mar 10, 2025 | $2.11M | $2.08M | -1.39% | -$0.40 | -$0.39 | +2.50% | — | — |
| Q4 2024 Nov 6, 2024 | $3.08M | $2.02M | -34.23% | -$0.44 | -$0.38 | +13.64% | — | — |
| Q3 2024 Aug 6, 2024 | $3.05M | $3.46M | +13.69% | -$0.45 | -$0.42 | +6.67% | — | — |
| Q2 2024 May 7, 2024 | $2.42M | $2.43M | +0.51% | -$0.39 | -$0.46 | -17.95% | — | — |
| Q1 2024 Mar 11, 2024 | $3.95M | $3.56M | -10.02% | -$0.22 | -$0.39 | -77.27% | — | — |
| Q4 2023 Nov 7, 2023 | $3.29M | $23.66M | +618.85% | -$0.38 | -$0.12 | +68.42% | — | — |
| Q3 2023 Aug 8, 2023 | $3.08M | $3.75M | +21.99% | -$0.49 | -$0.48 | +2.04% | — | — |
| Q2 2023 May 9, 2023 | $2.75M | $3.50M | +27.35% | -$0.48 | -$0.46 | +4.17% | — | — |
| Q1 2023 Mar 9, 2023 | $3.07M | $3.69M | +20.34% | -$0.47 | -$0.44 | +6.38% | — | — |
| Q4 2022 Nov 8, 2022 | $3.70M | $3.30M | -10.73% | -$0.48 | -$0.44 | +8.33% | — | — |
| Q3 2022 Aug 9, 2022 | $2.86M | $4.19M | +46.57% | -$0.37 | -$0.46 | -24.32% | — | — |
| Q2 2022 May 9, 2022 | $3.20M | $2.66M | -16.75% | -$0.35 | -$0.35 | +0.00% | — | — |
| Q1 2022 Mar 21, 2022 | $4.17M | $2.56M | -38.64% | -$0.34 | -$0.34 | +0.00% | — | — |
| Q4 2021 Nov 9, 2021 | $16.50M | $3.98M | -75.90% | -$0.12 | -$0.46 | -280.17% | — | — |
| Q3 2021 Sep 2, 2021 | — | $1.48M | — | $0.42 | -$1.55 | -469.05% | — | — |
| Q3 2021 Jul 23, 2021 | — | $1.59M | — | — | -$0.48 | — | — | — |